SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-190198
Filing Date
2015-05-15
Accepted
2015-05-15 16:06:58
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d899216d10q.htm 10-Q 263169
2 EX-31.1 d899216dex311.htm EX-31.1 5955
3 EX-31.2 d899216dex312.htm EX-31.2 6083
4 EX-32 d899216dex32.htm EX-32 3438
  Complete submission text file 0001193125-15-190198.txt   2122290

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bgmd-20150331.xml EX-101.INS 154830
6 XBRL TAXONOMY EXTENSION SCHEMA bgmd-20150331.xsd EX-101.SCH 26699
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bgmd-20150331_cal.xml EX-101.CAL 31482
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bgmd-20150331_def.xml EX-101.DEF 146748
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bgmd-20150331_lab.xml EX-101.LAB 207515
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bgmd-20150331_pre.xml EX-101.PRE 168048
Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33827 | Film No.: 15869297
SIC: 2835 In Vitro & In Vivo Diagnostic Substances